Article

QUALIblood, a spin-off for the medicine of tomorrow

One of the major concerns with the disease caused by Covid-19 is its severe course, which causes many problems that can lead to hospital overload. Early detection of whether or not a person is at risk of developing a severe form of the disease is therefore crucial to optimise patient care and hospital resource management. This is one of the objectives of the study carried out by QUALIblood, a UNamur spin-off, in collaboration with the Department of Pharmacy and many other industrial and hospital partners. Exploration of a cutting-edge technology at the service of health.
See content
Article

Yves Poumay, researcher on skin pathologies

As the largest and heaviest organ in the human body, the skin is the focus of Professor Yves Poumay's research. For nearly 30 years, within the Cells and Tissues laboratory (LabCeTi), he has been developing in vitro epidermal models that reproduce skin pathologies to better understand and treat them. A pioneering approach that offers alternatives to animal experimentation! On the eve of an international congress devoted to dermatology research organised at UNamur (see below), he talks about the importance of melanoma screening and details the latest advances in dermatology made in his laboratory.
See content
Article

An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart

On 13 December 2023, Charlotte Beaudart, a new academic at the University of Namur Faculty of Medicine, will be awarded a prize at the annual ceremony for Belgian scientific research in support of her innovative research on the subject of ageing.
See content
Event

Public thesis defense - Pauline TRICQUET

The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.
See content
Article

Is there a doctor in the village? Analysis by a sociologist

The lack of primary care is a major public health issue. In 2022, it was estimated that 52 municipalities in French-speaking Belgium were facing a severe shortage of general practitioners. This is a worrying situation that the University Observatory for Rural Medicine (OUMRu) has been addressing since 2023, with the aim of identifying concrete solutions. Working alongside a doctor and a health geographer, Amélie Pierre, a sociologist and lecturer at the Faculty of Economics, Management and Communication SciencesPo (EMCP), is studying the factors that influence access to healthcare, particularly from the patients' point of view. She emphasizes the need to take into account the realities experienced by vulnerable groups.
See content
Article

Skin infections: UNamur partners in Win²WAL research project

The TineaDiag project is a research project run by UNamur and ULiège with funding from the SPW Research Win²WAL program. It tackles dermatophytoses, skin infections responsible for ringworm, which can affect both humans and animals. The aim? To identify, in dermatophytes, precise cellular markers in order to detect them with sensitivity and certainty, and thus identify infections caused by antifungal-resistant strains.
See content
Article

Marc Hennequart, researcher at UNamur, receives a Grant from the Fondation contre le cancer (Cancer Foundation)

Since September 2023, Marc Hennequart, Professor of Biochemistry and Cell Biology at UNamur, has been conducting groundbreaking research into pancreatic cancer. His team, based at the Faculty of Medicine and the Institut Narilis, studies the early stages of oncogenesis (the process of transforming a normal cell into a cancerous one) to better understand the metabolic changes behind this particularly aggressive cancer.
See content
Article

Our researchers in the World's Top 2% Scientists list

Stanford University has published a prestigious ranking that highlights the most influential researchers in a wide range of scientific fields. The list, based on bibliographic criteria, aims to provide a standardized means of identifying the world's scientific leaders. It is one criterion among others for assessing the quality of scientific research. Twelve researchers from the University of Namur are among them!
See content
Article

A gift for labs in the Faculty of Science and Faculty of Medicine

In late November, the Mont-Saint-Guibert-based company Cellistic® donated equipment it no longer used to UNamur. By enabling the university to give this equipment a second life, Cellistic is making an important gesture in support of the development of university research.
See content
Article

An exploratory mission to forge ties with Senegal

A delegation from the Université de Namur took part in an exploratory mission to the Université Cheikh Anta Diop (UCAD) in Dakar, Senegal. The aim: to discover the research carried out in the field, meet UCAD researchers and initiate future collaborations between the two institutions.
See content
Article

Covid-19, five years on: A look back at UNamur's major role in the pandemic

The Covid-19 pandemic is a human tragedy that has caused millions of deaths worldwide and put our entire society under great strain. But it has also been a tremendous collective moment for many UNamur scientists, whose research continues in an attempt to better understand this disease and its consequences.
See content